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Abstract

The main goal of this research is to see how propionate, a common food preservative and an important
metabolite in humans, alters the activation of our immune system. The effects of propionate on macrophage
activation will be determined by using nitrite and LDH assays. For these assays, different concentrations of
propionate will be tested to determine how macrophages respond to the activation by LPS and interferon
gamma. Another goal of this project is to determine the effects of propionate and macrophage activation on
intracellular survival of L. monocytogenes. A gentamicin protection assay will be used to better establish
the role of multiple variables related to L. monocytogenes infection. These variables include the length and
level of propionate exposure prior to infection, macrophage activation state, and nitric oxide production.
From these experiments we investigated if over stimulation of anti-inflammatory SCFAs could lead to an
increase of susceptibility to L. monocytogenes infections. Results from these proposed experiments will
ultimately help us better understand how propionate affects host-pathogen interactions.
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Introduction
Rationale
The main goal of this research project is to determine the role of propionate in the
antimicrobial functions of macrophages against the intracellular pathogen Listeria
monocytogenes. It is important to gain a greater understanding into how the immune
system is regulated by different environmental factors that are present in the body.
Specifically, for this research, the effect of propionate on the immune system is examined
as it is one of the dominant short chain fatty acids (SCFAs) present in the gut during L.
monocytogenes infection. Further research into the effect of propionate on the immune
system will help determine if it could be used in a clinical setting to treat or prevent L.
monocytogenes and other infectious diseases.
We want to see if propionate can be used to naturally enhance our immune
responses before and during infection. If the data supports this claim, then propionate
could be used as a preventative measure before infection and could be used as a treatment
during an infection in conjunction with, or instead of, antibiotics. It is important to
establish other treatment options besides the primary use of antibiotics to the increasing
amounts of antibiotics resistant infections that are emerging. According to the CDC, 28
million people in the U.S. suffer from an antibiotic resistant infection and 35,000 of those
people die from these infections each year1. Increasing antibiotic resistance is due in part
to the overuse and misuse of antibiotics, which includes taking antibiotics for viral
infections, not finishing taking your antibiotics when you have an infection and by using
old, expired antibiotics from previous infections2. Additionally, incidence of antibiotic
resistance is also increasing because of the overuse of antibiotics in the manufacturing of
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the foods we eat, including livestock and crops. This can lead to the spread of antibiotic
resistant pathogens that are difficult to treat with the antibiotic options that we have
available1.
Therefore, as some infections become harder to treat successfully with antibiotics, it is
important to look into other treatment options. Specifically, in this research we are trying
to see if propionate could be used as a better, noninvasive, and cheaper alternative to
antibiotics that could prevent unnecessary deaths from antibiotic resistant infections in
the United States. In this research the pathogen L. monocytogenes was used to establish
the effects of propionate on the immune system during infection. Although L.
monocytogenes is not typically considered an antibiotic resistant pathogen3, it serves as a
good infection model to better understand how propionate and other environmental
factors can be used to modulate our immune response.

Listeria monocytogenes
L. monocytogenes is a Gram-positive bacterium and an opportunistic pathogen for
a variety of mammals. Listeria infection is most likely to occur in immunocompromised
individuals, pregnant women, and the elderly.
According to the Center for Disease Control,
approximately 1,600 people get infected by L.
monocytogenes and about 260 of those die from
infection each year4. Therefore, although L.
monocytogenes infections are rare, the high
mortality rate associated with complicated

Figure 1. A schematic showing key steps and
virulence factors in L. monocytogenes
intracellular life cycle. (Image credit: reference
[5])
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infections argue for a better understanding of the disease mechanisms to identify more
effective preventative measures.

Intracellular Life Cycle of Listeria monocytogenes
L. monocytogenes is an intracellular pathogen that is able to survive and replicate inside
host cells, such as macrophages. L. monocytogenes has a specific intracellular life cycle to
be able to grow in macrophages and to spread to neighboring cells. In the intracellular life
cycle of L. monocytogenes (Figure 1)5, surface proteins InlA and InlB are used to aid the
entry of L. monocytogenes into the host cell. Once inside the host cell, pore forming toxin
listeriolysin O (LLO) and phospholipase C are used to help L. monocytogenes escape from
the vacuole and into the cytosol. After the entry of the bacteria into the cytosol, L.
monocytogenes induces the polymerization of host actin filaments to form actin rockets
that allow L. monocytogenes to move from cell to cell.

Antimicrobial Functions of Macrophages
Macrophages are professional phagocytes that are important for detecting and
eliminating foreign materials. These cells can circulate throughout our body as well as
staying within specific tissues. They act as a major line of defense against bacterial
pathogens by providing a variety of antimicrobial functions. As phagocytes, macrophages
can engulf pathogens into intracellular phagosomes where degradation of the pathogen
takes place. For example, inducible nitric oxide synthase (iNOS) in macrophages
catalyzes the production of nitric oxide (NO), which contain both direct and indirect
antimicrobial effects6. NO is an inflammatory molecule that is able to directly damage
bacterial enzymes, resulting in decreased bacterial fitness and growth. Indirect effects of
NO occur when NO reacts with reactive oxygen species to general additional oxidative

Page | 4

stress for the intracellular bacteria. When NO is diffused into the lumen of phagosomes, it
reacts with superoxide to form peroxynitrite (ONOO-)6, which modifies bacterial proteins
and DNA to further intoxicate the ingested microbes. Together, these oxygen and
nitrogen radicals provide a strong oxidative defense against engulfed pathogens.

Activation of NO Production in Macrophages Against Listeria
monocytogenes
The production of NO is tightly regulated in macrophages partly through the
regulation on the expression of iNOS. In the presence of pro-inflammatory cytokines
(such as interferon gamma) and bacterial ligands (such as lipopolysaccharides), naive
macrophages are activated so that genes relevant to antimicrobial activities or
inflammation are upregulated. Expectedly, intracellular growth of L. monocytogenes in
activated bone marrow-derived macrophages (BMDMs) was significantly compromised
compared to growth in naive BMDMs7. Specifically, for iNOS, increased levels of NO in
BMDM were shown to prevent the escape of L. monocytogenes from the vacuole into the
cytoplasm7. Moreover, in another study, increased localization of iNOS in the phagosome
of activated BMDMs by a deubiquitinase (DUB) inhibitor resulted in enhanced killing of
intracellular L. monocytogenes8.

Short Chain Fatty Acids
Numerous other physiological signals also contribute to the regulation of
macrophage activities, potentially influencing infection outcomes. For example, short
chain fatty acids (SCFAs) have been reported to exhibit anti-inflammatory effects9 and
can potentially alter L. monocytogenes infections in macrophages. In the intestinal lumen,
SCFAs are a subset of fatty acids with less than six carbon atoms. SCFAs, such as
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propionate, butyrate, and acetate, are produced in the gut microbiota from the bacterial
fermentation of hard to digest foods such as dietary fibers10. Our lab has previously
shown that propionate, one of the dominant SCFAs, exhibits a strong effect on L.
monocytogenes fitness and toxin production11. Because SCFA levels are heavily
influenced by an individual’s diet12, understanding the function of SCFAs presents a
unique opportunity to use noninvasive, dietary measures to prevent L. monocytogenes
infections. Alternatively, this understanding will also help us identify if there are dietary
regimens that can potentially increase susceptibility to L. monocytogenes infections and
need to be avoided for high-risk individuals. Specifically, propionate could be used as a
food additive or supplement to enhance the immune response and prevent infection by
infectious diseases. For my thesis research, I am hypothesizing that if SCFAs are antiinflammatory, exposure to SCFAs by macrophages might lead to a reduced NO
production, allowing the growth of more intracellular L. monocytogenes. If this were true,
despite the known health benefits of SCFAs9, over-stimulation of SCFA production
might pose a potential threat to increasing individual susceptibility to L. monocytogenes
infections. Therefore, my honors thesis focuses on determining the role of propionate,
one of the dominant SCFAs, in the antimicrobial functions of macrophages against L.
monocytogenes.

Methods
Listeria monocytogenes Culture
For this research the wild type 10403s Listeria monocytogenes bacterial strain
was cultured overnight (15-18 hours) in 2 mL of filter sterilized brain heart infusion
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(BHI) media. For each culture, 1-2 colonies were placed into the media. The aerobic L.
monocytogenes cultures were incubated at 37°C and agitated at 250 rpm. The anaerobic
L. monocytogenes cultures were also incubated at 37°C, but they were placed inside an
anaerobic chamber (COY Laboratory) and were not shaken. The environment of the
anaerobic chamber consisted of nitrogen and about 2.5% hydrogen.

RAW264.7 Macrophage Culture
RAW264.7 mouse peritoneal macrophage cell line (ATCC) were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) (VWR) with 10% (v/v) fetal bovine serum
(Fisher Scientific) and penicillin-streptomycin (5000 µg/mL, Fisher Scientific). The
macrophages were incubated at 37°C, with 5% CO2 in either 96-well or 24-well tissue
culture plates for 16-18 hours. A total of 6.0 x 106 macrophages were maintained in each
plate at 1 mL per well. Macrophages were also activated with 1 ng/mL
lipopolysaccharides (Sigma Aldrich) and 10 ng/mL interferon gamma for 16-18 hours.

Nitrite Assay
The level of nitrite is measured as an indicator for nitric oxide production.
RAW264.7 cells, without or with activation by 1 ng/mL LPS and 10 μg/mL IFN-y in
phenol-free DMEM (VWR), were seeded in either a 96-well or 24-well tissue culture
plate (6 x 106 cells per plate). The cells were treated with varying concentrations of
propionate (0, 0.1, or 1 mM) for 3 or 16-18 hours (see Table 1 below for detailed
organization of the treatments used). Nitric oxide (NO) production of these cells were
determined by measuring the nitrite concentration in the cell culture media. Briefly, 100
μl of cell culture supernatant was mixed with 100 μl of Griess reagent (1:1 of 1% [wt/vol]
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sulfanilamide in water and 0.1% [wt/vol] naphthyl ethylenediamine dihydrochloride in
10% [vol/vol] hydrochloric acid), which is made fresh on a weekly basis. The absorbance
was measured at 560 nm after incubation at room temperature for 5 minutes using a 96well plate reader (BioTek). A sodium nitrite (NaNO2) standard curve was used to
calculate nitrite concentrations in the samples.

Cells

Treatments

Treatment Options

Listeria

Oxygen level

Aerobic or Anaerobic

Macrophage

Activation

± IFNγ/LPS

Propionate

0, 0.1, 1, or 10 mM

Duration of propionate treatment

3 or 16-18 hours

Table 1. Different treatments of L. monocytogenes and macrophages to assess the effects of
propionate on the phagocytic activities of macrophages against L. monocytogenes.

Gentamicin Protection Assay
Gentamicin Protection Assays were used to determine the intracellular colony
forming units (CFU) and percent survival of aerobically or anaerobically cultured L.
monocytogenes within macrophages. RAW264.7 macrophage cells were seeded at 6 x
106 cells per plate concentration in a 24-well tissue culture plate and were activated with
1 mg/mL LPS and 10 ng/mL IFN-ɣ for 16-18 hours overnight. The next day, the DMEM
was removed from all of the wells and new phenol red-free DMEM was added with
either 0, 1, or 10 mM propionate treatments. The cells were incubated at 37°C for 3 hours
with the additional propionate treatments and the overnight cultures of L. monocytogenes
were prepared for infection. First, the L. monocytogenes cultures were washed with
Dulbecco’s phosphate buffered saline (DPBS) and then they were normalized to a
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multiplicity of infection of 10. This was achieved by diluting the cultures with calculated
proportional volumes of DMEM. After the cells were treated with propionate for 3 hours,
the DMEM was removed from the wells and 500 μl of either aerobically or anaerobically
grown L. monocytogenes were added to infect the cells. After 30 minutes of infection, the
cells were washed with DPBS (VWR) and 1 mL of 10 mg/mL gentamicin (VWR)
DMEM mixture was added to each well to eliminate extracellular bacteria. At 2 hours
post infection, the cells were lysed with sterile deionized water and 50 μl of the lysate
was plated on LB media plates. After 2 days, the colonies of L. monocytogenes on each
plate (CFU) were counted with a BioTek plate reader.

Lactate Dehydrogenase (LDH) Assay
LDH assays were performed to observe if propionate had any cytotoxic effect on
the macrophage cells. RAW264.7 cells, with or without activation by IFN-y and LPS in
phenol-free DMEM, were seeded in a 96-well plate for 16-18 hours. The cells were also
treated with either 0, 0.1, or 1 mM propionate 16-18 prior to performing the assay. The
assay was performed with a commercially available LDH assay kit from Fisher Scientific
following manufacturer’s instructions. Briefly, 50 μl of the cell supernatant was
transferred to a new 96-well plate and was combined with 50 μl of assay buffer. After 30
minutes of incubation, 50 μl of stop solution was added to the wells. Then, 150 μl of each
sample was transferred to a 96 well plate and their absorbance was measured at 480 nm.
For the lysis control of the assay, the original plate was used, and the liquid was aspirated
from the wells. Then, the cells were washed with DPBS and 90 μl of diluted lysis buffer
was added to the wells. After 45 minutes of incubation, 50 ul of the lysate was added to a
new 96 well plate containing 50 μl of reaction mixture. After a 30-minute incubation, 50
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μl of stop solution was added to the samples and the absorbance was measured at 490 nm
and 680 nm. Cell death was expressed as the percentage of total lysis and was calculated
by (test LDH release - spontaneous release)/(maximum release - spontaneous release) x
100.

Results and Discussion
Nitrite Assay
To investigate the effect of propionate on macrophages, I first performed nitrite
assays in the absence of L. monocytogenes infection. Nitrite assays were used to measure
nitric oxide production (via nitrite concentration) of naive or activated macrophages that
were treated with 0, 1, or 10 mM concentrations of propionate. Figure 2 shows the
results of these assays that were performed across 4 independent experiments. It was
observed that 16-18 hours of propionate treatment had no significant effect on the nitric
oxide production of naive macrophages. Conversely, nitric oxide production was
suppressed with increasing concentrations of propionate in activated macrophages. As
nitric oxide production is correlated with increased antimicrobial activity of
macrophages, these results suggest that in the absence of infection, propionate has no
observed effect on the antimicrobial activity of naive macrophages. Moreover, propionate
decreases the antimicrobial activity of activated macrophages. These findings tell us that
propionate may not be a good supplement to use before infection, as it is shown here to
decrease the antimicrobial activity of macrophages. This is likely due to the antiinflammatory nature of propionate depressing our immune response and therefore
reducing the amount of nitric oxide produced by macrophages.
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Figure 2 Nitrite concentration of naive and activated macrophages after propionate treatment for
16-18 hours. Activated macrophages were also treated with LPS and IFN-γ overnight (16-18
hours). These experiments were conducted in a 96-well plate with 4 replicates for each treatment.
This graph shows averages of data from 4 independent experiments.

LDH Assay
To ensure that the decrease in nitric oxide production was not a result of
propionate causing cell death or cytotoxicity to macrophage cells, LDH assays were
performed. LDH is used as an indicator for cytotoxicity as it is released into the cell
supernatant when the cell’s plasma membrane is damaged (citation). Figure 3 shows the
results of an LDH assay performed in a 96-well plate with 4 replicates of each condition.
This graph also consists of data averaged across 3 independent experiments. I observed
that for naïve macrophages, the 1 mM propionate treatment significantly increased the
amount of released LDH. In contrast, propionate treatment did not significantly affect the
amount of released LDH. These results suggest that propionate treatment may cause
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some cytotoxicity for naive macrophages. This data contradicts previous findings in our
lab, that showed propionate concentrations up to 25 mM had no cytotoxic effect on
macrophage cells. In the future, this experiment should be repeated to test the accuracy of
this finding.

Figure 3 LDH activity of macrophages after propionate treatment for 16-18 hours. Activated
macrophages were also treated with LPS and IFN-γ overnight (16-18 hours). This graph is
composed of data taken from 3 independent experiments.

Nitrite Assay with Infection
To establish the effect of propionate on immune cells during an infection, we first
pre-treated naive and activated macrophages for 3 hours with propionate. After pretreatment, these macrophages were infected with aerobically or anaerobically grown L.
monocytogenes and the nitric oxide production of the cells were measured via a nitrite
assay performed at 24 hours post infection. Figure 4 demonstrates the results of these
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experiments performed in a 24-well plate with 3 replicates each. It was noted that overall,
3 hours of propionate pre-treatment prior to infection was not a sufficient amount of time
to observe differences in the nitric oxide production of both naive and activated
macrophages. However, infection with aerobic or anaerobic L. monocytogenes did
contribute to changes in the nitric oxide production of both naive and activated
macrophages. Specifically, in naive macrophages, those that were infected with aerobic
bacteria had significantly decreased nitric oxide production then those that were infected
with anaerobic bacteria. A similar effect was observed in activated macrophages, as the
cells that were treated with aerobic bacteria also had significantly less nitric oxide
production then those that were treated with anaerobic bacteria.
Taken together, these results suggest macrophages that are infected with
anaerobic L. monocytogenes produce more nitric oxide and have more antimicrobial
activity then macrophages that are infected with aerobic L. monocytogenes. From this, it
can be inferred that macrophages have the ability to differentiate between aerobic and
anaerobic bacteria. To better understand this finding, more research needs to be
conducted into the effects of oxygen exposure on the antimicrobial activity of
macrophages. It will also be helpful to do more research into the different levels of
oxygen that L. monocytogenes and macrophages experience within the different
environments of the gut microbiome. Lastly, if these experiments were replicated, I
would treat the macrophages with propionate for longer than 3 hours prior to infection to
see if there would be a stronger effect on the nitric oxide production of macrophages.
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Figure 4 Nitrite concentration of naive and activated macrophages infected with aerobic and
anaerobic L. monocytogenes. Macrophage cells were seeded overnight with LPS and IFN-y for
16-18 hours and treated the next day with propionate for 3 hours. After propionate treatment,
cells were infected for 3 min and nitrite concentration measurements were recorded 24 hours post
infection.
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Intracellular CFU of Infected Macrophages
To investigate the effects of propionate on immune cells, we used naive and
activated macrophages and assayed for intracellular bacterial CFU after a 3-hour pretreatment with propionate. Cells were infected with aerobically or anaerobically grown L.
monocytogenes for 30 minutes and were plated 24 hours post infection. Figure 4 shows
the CFU/well for each macrophage treatment. For both naive and activated macrophages
it was observed that there was no significant difference in the CFU/well between the
different propionate treatments tested. However, as presented in the first two graphs of
the figure, we noticed that the CFU/well of naive macrophages was significantly greater
than the CFU/well of activated macrophages that were treated with propionate. This data
supports previous research, as activated macrophages are expected to have more
antimicrobial activity than naive macrophages. With more antimicrobial activity, then
these macrophages are able to engulf and kill more L. monocytogenes, resulting in the
decreased amounts of CFU/well that were observed.
Additionally, the third graph of the figure shows that there was no significant difference
in CFU/well when naive macrophages were infected with aerobic or anaerobic bacteria.
This data implicates that the antimicrobial activity of macrophages is not changed when
they encounter L. monocytogenes with different levels of oxygen exposure. There also is
no significant difference between the treatments of this data, because of standard
deviation and variation between the data recorded. Lastly, the fourth graph of this figure
shows that the CFU/well of activated macrophages are significantly decreased when they
are infected with anaerobic L. monocytogenes. This data correlates with the data from

Page | 15

figure 4, as the increased nitric oxide levels were also observed in activated macrophages
that were infected with anaerobic L. monocytogenes. This data suggests that activated
macrophages can enhance their immune response when they are exposed to anaerobic L.
monocytogenes. With this data in mind, it would be important in clinical settings to treat
infections by facultative pathogens such as L. monocytogenes differently than how
infections by obligate pathogens may be treated.
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Figure 5 Intracellular CFU/well of naive and activated macrophages that were pre-treated with
propionate for 3 hours. Macrophages were infected for 30 minutes with aerobically and
anaerobically grown L. monocytogenes. Cells were plated at 24 hours post infection and were
diluted serially diluted with sterile water by a factor of 1:1000. First two graphs compare the
CFU/well of naive vs activated macrophages that were both infected with either aerobic or
anaerobic bacteria. The second graphs compare the CFU/well of macrophages infected with
aerobic vs anaerobic L. monocytogenes. For each treatment there were 3 triplicates, and the data
was averaged from 2 different experiments.
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